prevention of osteoporosis Osteoporosis
burden of osteoporosis
effects of colostrum
innovative nutraceutical product
innovative product
knowledge
nutraceutical agent
lack expertise
product development
creation
new product
innovative agents
Nutraceutical supplementation
intersectorial collaboration
bone metabolism
intersectorial secondments
academic institutions lack
bone loss
use of pharmacological agents
pharmacological drugs
gap
industrial institutions
promising agent
research skills
inefficiency of current drugs
economic burden of osteoporotic fractures
major public health concern
ideas
attention
industry
market
absence
advantage
natural constituents
hand
scientific community
estimates
matter
application
need
possibility
COLOSTEO
accordance
consequence
aim